Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.13
91% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $403.7K | $20.9K | $2.6K | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $28.1K | $42.5K | $15.4K | $8.5K | $2.3K |
| Gross profit | $403.7K | $20.9K | $2.6K | −$28.1K | −$42.5K | −$15.4K | −$8.5K | −$2.3K |
| Gross margin | 100.0% | 100.0% | 100.0% | — | — | — | — | — |
| R&D | $0 | $0 | $35.8M | $571.0K | $574.4K | $312.6K | $16.1K | $0 |
| Operating income | −$1.6M | −$280.0K | −$190.0K | −$3.4M | −$2.9M | −$976.3K | −$395.5K | −$861.4K |
| EBITDA | −$1.1M | −$192.1K | $36.5M | −$3.4M | −$2.9M | −$1.0M | −$395.5K | −$859.1K |
| Net income | −$1.1M | −$364.0K | −$190.0K | −$4.3M | −$3.0M | −$1.2M | −$260.5K | −$865.3K |
| Net margin | -281.1% | -1739.4% | -7341.6% | — | — | — | — | — |
| EPS (diluted) | -0.12 | -0.04 | -0.02 | -0.06 | -0.04 | -0.02 | -0.00 | -0.01 |
Annual figures · source: Financial Modeling Prep
BIOMIND LABS INC
No one on the platform currently holds BMNDF.
No tracked institution reports a position in BMNDF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-07-30 | 1-for-32.5reverse |
No one on the platform has traded BMNDF yet.
| $555323 |
| — |
| ENZCEnzolytics Inc. | $0.00 | +0.00% | $4M | — |
| EVFMEvofem Biosciences, Inc. | $0.01 | +0.00% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.